Featured Research

from universities, journals, and other organizations

Stereotactic Radiotherapy Offers Noninvasive, Effective Treatment For Lung Cancer Patients

Date:
November 12, 2009
Source:
UT Southwestern Medical Center
Summary:
Stereotactic body radiation therapy should be considered a new standard of care for early-stage lung cancer treatment in patients with co-existing medical problems, according to results from a national clinical trial.

Stereotactic body radiation therapy (SBRT) should be considered a new standard of care for early-stage lung cancer treatment in patients with co-existing medical problems, according to results from a national clinical trial led by UT Southwestern Medical Center physicians.

In this study, 55 patients diagnosed with early non-small-cell lung (NSCL) cancer and unable to have their tumors surgically removed because of unrelated medical comorbidities were treated with SBRT during three noninvasive outpatient treatments.

The most recent findings, presented today in Chicago at the 51st annual meeting of the American Society for Therapeutic Radiology and Oncology, show that the primary lung cancer did not recur 98 percent of the time. Despite their extreme frailty, more than half of these patients -- 56 percent -- were alive three years after diagnosis, while less than 20 percent ultimately died of metastatic lung cancer.

"These findings have changed the standard of care for lung cancer in patients with serious medical problems like emphysema, heart disease and strokes," said Dr. Robert Timmerman, vice chairman of radiation oncology at UT Southwestern and principal investigator of the Radiation Therapy Oncology Group (RTOG) 0236 study.

SBRT delivers multiple high-dose radiation beams to a tumor in a concentrated, extremely precise manner. Each of these beams is relatively weak and causes very little damage when traveling through the patient's body, but when all the beams converge at the target their cumulative effect delivers an extremely potent dose aimed at destroying the target cells with great precision.

"Despite the high potency of the treatment, less than 20 percent of these extremely frail patients experienced a serious health decline," said Dr. Timmerman, considered one of the top international experts on stereotactic radiotherapy.

Dr. Timmerman said the study results were better than researchers had expected and are similar to the risks for healthier patients who undergo radical surgery -- the standard treatment for early-stage NSCL cancer for the past century.

"The findings support the ongoing clinical research in healthier patients who currently undergo surgery for early-stage NSCL cancer," Dr. Timmerman said. "SBRT is fast, convenient and very effective."

Dr. Timmerman and his team, hoping to find out if the treatment indications might be expanded in a new trial, currently are conducting clinical studies using SBRT in healthier patients who would otherwise be candidates for surgery.


Story Source:

The above story is based on materials provided by UT Southwestern Medical Center. Note: Materials may be edited for content and length.


Cite This Page:

UT Southwestern Medical Center. "Stereotactic Radiotherapy Offers Noninvasive, Effective Treatment For Lung Cancer Patients." ScienceDaily. ScienceDaily, 12 November 2009. <www.sciencedaily.com/releases/2009/11/091102121458.htm>.
UT Southwestern Medical Center. (2009, November 12). Stereotactic Radiotherapy Offers Noninvasive, Effective Treatment For Lung Cancer Patients. ScienceDaily. Retrieved July 29, 2014 from www.sciencedaily.com/releases/2009/11/091102121458.htm
UT Southwestern Medical Center. "Stereotactic Radiotherapy Offers Noninvasive, Effective Treatment For Lung Cancer Patients." ScienceDaily. www.sciencedaily.com/releases/2009/11/091102121458.htm (accessed July 29, 2014).

Share This




More Health & Medicine News

Tuesday, July 29, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Deadly Ebola Virus Threatens West Africa

Deadly Ebola Virus Threatens West Africa

AP (July 28, 2014) West African nations and international health organizations are working to contain the largest Ebola outbreak in history. It's one of the deadliest diseases known to man, but the CDC says it's unlikely to spread in the U.S. (July 28) Video provided by AP
Powered by NewsLook.com
$15B Deal on Vets' Health Care Reached

$15B Deal on Vets' Health Care Reached

AP (July 28, 2014) A bipartisan deal to improve veterans health care would authorize at least $15 billion in emergency spending to fix a veterans program scandalized by long patient wait times and falsified records. (July 28) Video provided by AP
Powered by NewsLook.com
Two Americans Contract Ebola in Liberia

Two Americans Contract Ebola in Liberia

Reuters - US Online Video (July 28, 2014) Two American aid workers in Liberia test positive for Ebola while working to combat the deadliest outbreak of the virus ever. Linda So reports. Video provided by Reuters
Powered by NewsLook.com
Traditional African Dishes Teach Healthy Eating

Traditional African Dishes Teach Healthy Eating

AP (July 28, 2014) Classes are being offered nationwide to encourage African Americans to learn about cooking fresh foods based on traditional African cuisine. The program is trying to combat obesity, heart disease and other ailments often linked to diet. (July 28) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins